Related references
Note: Only part of the references are listed.The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV
Philipp Kohler et al.
AIDS (2015)
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
Tomas Doyle et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Wan-Lin Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
Soo-Yon Rhee et al.
PLOS MEDICINE (2015)
Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013
Joanne D. Stekler et al.
ANTIVIRAL THERAPY (2015)
Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals
A. Gonzalez-Serna et al.
CLINICAL INFECTIOUS DISEASES (2014)
Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel
Huldrych F. Guenthard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients
Alexandra U. Scherrer et al.
PLOS ONE (2012)
Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy
Benjamin Young et al.
ANTIVIRAL THERAPY (2011)
Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient
Sarita D. Boyd et al.
ANTIVIRAL THERAPY (2011)
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
Roger D. Kouyos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors
Francesca Ceccherini-Silberstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cohort Profile: The Swiss HIV Cohort Study
Franziska Schoeni-Affolter et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Share Paper
